SCHEMBL24933608

SCHEMBL24933608

COC(=O)c1cnccc1C1CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 3/20 0.53
GLA P06280 2/20 0.53
GAA P10253 2/20 0.53
LMNA P02545 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
PDK2 Q15119 1/20 0.42
PDK4 Q16654 1/20 0.42
CYP17A1 P05093 1/20 0.41
KDM4C Q9H3R0 2/20 0.41
KMT2A Q03164 1/20 0.40
SSTR4 P31391 1/20 0.40
IDO1 P14902 1/20 0.40
CYP46A1 Q9Y6A2 1/20 0.40
MAPK8 P45983 1/20 0.39
MAPK9 P45984 1/20 0.39
MAPK10 P53779 1/20 0.39
HSD17B10 Q99714 3/20 0.39
HTT P42858 2/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30753067 1.00 KDM4E (0.53) KDM4EALDH1A1GLAGAALMNA
SCHEMBL7276717 0.92 ALDH1A1 (0.49) KDM4EALDH1A1GLAGAALMNA
SCHEMBL21056638 0.87 KDM4E (0.57) KDM4EALDH1A1GLAGAALMNA
SCHEMBL31496912 0.86 KDM4C (0.48) KDM4EALDH1A1GLAGAAL3MBTL1
SCHEMBL9208694 0.84 KDM4E (0.47) KDM4EALDH1A1GLAGAALMNA
SCHEMBL6630041 0.81 IDO1 (0.42) CYP17A1KDM4CSSTR4IDO1
SCHEMBL2417380 0.81 GPR119 (0.55) KDM4EALDH1A1KMT2AHSD17B10HPGD
SCHEMBL30053721 0.81 KDM4C (0.48) KDM4EALDH1A1L3MBTL1KDM4CKMT2A
SCHEMBL26599184 0.79 KDM4E (0.48) KDM4EALDH1A1GLAGAALMNA
SCHEMBL68952 0.77 KDM4E (0.70) KDM4EALDH1A1GLAGAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117980292-A Substituted pyridone compounds for the treatment of orthomyxoviral infections 诺华股份有限公司 2024-05-03 CN disclosed
WO-2023002443-A1 SUBSTITUTED PYRIDONE COMPOUNDS USEFUL TO TREAT ORTHOMYXOVIRUS INFECTIONS NOVARTIS AG (CH) 2023-01-26 WO disclosed